Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care

Immune checkpoint inhibitors (ICIs) have improved outcomes for many patients with advanced cancers. However, managing the immune-related adverse events (irAEs) associated with these agents is challenging. Late recognition and/or inadequate irAE management can result in ICI discontinuation or termina...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffner, Brianna, Rubin, Krista M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522662/
https://www.ncbi.nlm.nih.gov/pubmed/33014514
http://dx.doi.org/10.6004/jadpro.2019.10.2.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522662/
https://www.ncbi.nlm.nih.gov/pubmed/33014514
http://dx.doi.org/10.6004/jadpro.2019.10.2.10

Ejemplares similares